Literature DB >> 33747198

Occurrence of quadruple squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation for leukemia: A case report.

Chunhong Hu1, Xue Wang2, Yue Pan1, Long Shu1, Fang Wu1.   

Abstract

The present case study investigated a rare case of quadruple squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation (HSCT) for leukemia. The main aim of the case study was to determine the pathogenesis and provide novel methods for the diagnosis and treatment of similar cases. The presence of genetic mutations in the p53, EGFR, KRAS and BRAF genes were analyzed and the presence of microsatellite instability (MSI) was determined. In addition, the expression levels of the proteins p53 and EGFR were investigated. The results identified a genetic mutation in p53, of which its expression levels were upregulated. In addition, the majority of the tumor tissues presented with MSI. Therefore, the present findings suggested that the genetic mutations in p53 caused by MSI following allogeneic HSCT may promote tumorigenesis. In addition, the expression levels of the EGFR protein were upregulated, leading to an increase in MAPK signaling pathway activation, which may also serve an important role.
Copyright © 2021, Spandidos Publications.

Entities:  

Keywords:  graft-versus-host disease; hematopoietic cell transplantation; immune state; multiple primary carcinomas; p53

Year:  2021        PMID: 33747198      PMCID: PMC7967950          DOI: 10.3892/ol.2021.12602

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   3.111


  39 in total

1.  Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.

Authors:  Navneet S Majhail; Ruta Brazauskas; J Douglas Rizzo; Ronald M Sobecks; Zhiwei Wang; Mary M Horowitz; Brian Bolwell; John R Wingard; Gerard Socie
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

2.  Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.

Authors:  Masakatsu Fukuda; Takashi Nakatsuka; Kaoru Kusama; Hideaki Sakashita
Journal:  J Oral Maxillofac Surg       Date:  2006-11       Impact factor: 1.895

3.  The equivalent efficacy of multiple operations for multiple primary lung cancer and a single operation for single primary lung cancer.

Authors:  Liang Dai; He-Li Yang; Wan-Pu Yan; Zhen Liang; Hong-Chao Xiong; Xiao-Zheng Kang; Yong-Bo Yang; Hao Fu; Meng-Ying Fan; Ke-Neng Chen
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

4.  Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.

Authors:  D Shanis; P Anandi; C Grant; A Bachi; N Vyas; M A Merideth; P A Pophali; E Koklanaris; S Ito; B N Savani; A J Barrett; M Battiwalla; P Stratton
Journal:  Bone Marrow Transplant       Date:  2017-10-16       Impact factor: 5.483

5.  Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study.

Authors:  Claire M Vajdic; Eleni Mayson; Anthony J Dodds; Tracey O'Brien; Leonie Wilcox; Ian Nivison-Smith; Renate Le Marsney; Benjamin Daniels; Lesley J Ashton
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-06       Impact factor: 5.742

6.  Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study.

Authors:  Rochelle E Curtis; Catherine Metayer; J Douglas Rizzo; Gérard Socié; Kathleen A Sobocinski; Mary E D Flowers; William D Travis; Lois B Travis; Mary M Horowitz; H Joachim Deeg
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

7.  Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia.

Authors:  M Themeli; L Petrikkos; M Waterhouse; H Bertz; E Lagadinou; N Zoumbos; J Finke; A Spyridonidis
Journal:  Leukemia       Date:  2010-01-14       Impact factor: 11.528

8.  New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy.

Authors:  Gang Guo; Yan Cui
Journal:  J Immunother Cancer       Date:  2015-03-24       Impact factor: 13.751

9.  RNF128 Promotes Invasion and Metastasis Via the EGFR/MAPK/MMP-2 Pathway in Esophageal Squamous Cell Carcinoma.

Authors:  Jing Gao; Yang Wang; Jie Yang; Weixia Zhang; Kun Meng; Yue Sun; Yangjia Li; Qing-Yu He
Journal:  Cancers (Basel)       Date:  2019-06-18       Impact factor: 6.639

10.  Non-cell-autonomous tumor suppression by p53.

Authors:  Amaia Lujambio; Leila Akkari; Janelle Simon; Danielle Grace; Darjus F Tschaharganeh; Jessica E Bolden; Zhen Zhao; Vishal Thapar; Johanna A Joyce; Valery Krizhanovsky; Scott W Lowe
Journal:  Cell       Date:  2013-04-04       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.